Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary /
保存先:
| 第一著者: | |
|---|---|
| 共著者: | , |
| その他の著者: | , |
| フォーマット: | 電子媒体 eBook |
| 言語: | 英語 |
| 出版事項: |
Washington, D.C. :
National Academies Press,
2011.
|
| 主題: | |
| オンライン･アクセス: | An electronic book accessible through the World Wide Web; click to view |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
| LEADER | 00000nam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | 0000130415 | ||
| 005 | 20171002061022.0 | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 110215s2011 dcu sb 000 0 eng d | ||
| 020 | |z 9780309163248 | ||
| 020 | |z 0309163242 | ||
| 035 | |a (CaPaEBR)ebr10443278 | ||
| 035 | |a (OCoLC)707927323 | ||
| 040 | |a CaPaEBR |c CaPaEBR | ||
| 050 | 1 | 4 | |a R853.B54 |b M33 2011eb |
| 100 | 1 | |a Mack, Alison. | |
| 245 | 1 | 0 | |a Perspectives on biomarker and surrogate endpoint evaluation |h [electronic resource] : |b discussion forum summary / |c Alison Mack, Erin Balogh, and Christine M. Micheel ; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c 2011. | ||
| 300 | |a x, 129 p. | ||
| 504 | |a Includes bibliographical references (p. 99-102). | ||
| 533 | |a Electronic reproduction. |b Palo Alto, Calif. : |c ebrary, |d 2011. |n Available via World Wide Web. |n Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | |a Biochemical markers. | |
| 655 | 7 | |a Electronic books. |2 local | |
| 700 | 1 | |a Balogh, Erin. | |
| 700 | 1 | |a Micheel, Christine. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. | |
| 710 | 2 | |a ebrary, Inc. | |
| 856 | 4 | 0 | |u http://site.ebrary.com/lib/daystar/Doc?id=10443278 |z An electronic book accessible through the World Wide Web; click to view |
| 908 | |a 170314 | ||
| 942 | 0 | 0 | |c EB |
| 999 | |c 119564 |d 119564 | ||